Extrovis is a fully integrated global pharmaceutical company with strong portfolio offering, comprising of Active Pharmaceutical Ingredients (APIs), Finished dosage forms (FDF) & Custom Pharmaceutical Services. Based in Switzerland, with global presence in North America, India and South America, we are supported by strong network to deliver products across geographies. Our state-of-the-art manufacturing facilities and R&D centers comply with highest international quality standards with accreditions from the USFDA, PMDA, EU and other global regulatory bodies. Our contributions in the area of education and health to financially under privileged reinforces our social commitment. Our mission is to become a reliable partner by offering high quality APIs, FDFs, custom pharmaceutical services and delivering value to our customers, stake holders and patients. Backed by our EXTROrdinary VISion, we have our eyes set on becoming a leading pharmaceutical company in the world.
View Top Employees from EXTROVIS| Website | http://extrovis.com/ |
| Revenue | $4 million |
| Employees | 167 (82 on RocketReach) |
| Phone | +41 41 740 11 19 |
| Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Pharmaceutical Manufacturing, Pharmaceutical Products, Active Pharmaceutical Ingredients, Finished Dosage Forms, Pharmaceutical Research |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular EXTROVIS employee's phone or email?
EXTROVIS Questions
The EXTROVIS annual revenue was $4 million in 2024.
Janos Vaczi is the Managing Director of EXTROVIS.
82 people are employed at EXTROVIS.
The NAICS codes for EXTROVIS are [32, 3254, 32541, 325].
The SIC codes for EXTROVIS are [283, 28].
Top EXTROVIS Employees
-
3
-
1
-
1
-
3
-
11
Related Companies
